Journal of Allergy

Research Article

Factors Associated with the Use of Different Treatment Modalities among Patients with Upper Airway Diseases in Taiwan: A Cross-Sectional Survey Study

Table 3

Multivariate logistic regression analysis of factors associated with the use of treatment modalities in patients with rhinitis ( ).
VariableOdds ratio (95% confidence interval),
pharmacology
239 (85.7%)		Subgroup of Pharmacology Surgical intervention
107 (38.4%)		 Traditional Chinese medicine
96 (34.4%)		 Nasal irrigation
95 (34.1%)
Oral
medications
215 (77.1%)		Topical medications
184 (65.9%)
Sex      
 Female   1.00  
 Male   2.11 (1.20–3.70), 0.009  
Educational level
 High school or above
 Elementary school or below		1.00
5.23 (1.74–15.73), 0.003		1.00
2.31 (1.12–4.76), 0.024		1.00
2.50 (1.32–4.74), 0.005		   
General health status      
 Good 1.00 1.001.00  
 Poor or fair 6.48 (1.41–29.86), 0.016 4.47 (1.85–10.80), 0.0010.92 (0.47–1.81), 0.805  
 Very good or excellent1.15 (0.51–2.60), 0.746 0.78 (0.42–1.42), 0.4090.32 (0.15–0.66), 0.002  
Smoking      
 No     1.00
 Yes     2.72 (1.39–5.30), 0.003
Alcohol use      
 No1.00     
 Yes2.52 (1.01–6.27), 0.047     
CRSOM-31 symptom-impact score
  116
 117–205
  205		1.00
4.35 (1.68–11.28), 0.002
2.20 (0.91–5.33), 0.081		1.00
2.70 (1.33–5.46), 0.006
2.46 (1.24–4.89), 0.010		  1.00
1.79 (0.90–3.57), 0.098
5.43 (2.79–10.60), 0.001		 
Allergic rhinitis
 No
 Yes		  1.00
2.37 (1.16, 4.86), 0.018		   
Deviation of nasal septum
 No
 Yes		    1.00
2.37 (1.19–4.72), 0.014		 
Chronic rhinosinusitis
 No
Without nasal polyps
 With nasal polyps		  1.00
2.55 (1.18–5.51), 0.018
3.76 (1.54–9.13), 0.004		1.00
2.11 (1.20–3.70), 0.009
2.45 (1.35–4.44), 0.003		 1.00
1.93 (1.07–3.49), 0.029
4.28 (2.09–8.76), 0.001
Other variables evaluated during model development included age, body mass index, marital status, exercise, and chronic hypertrophic rhinitis.